Search research articles
Contact Us
Filters
Showing results (641-650 of 1,005) with videos related to
Page
of 101
Sort By:
Human Molecular Genetics
|
August 14, 2010
Transcriptional profiling of fibroblasts from patients with mutations in MCT8 and comparative analysis with the human brain transcriptome
W Edward Visser, Sigrid M A Swagemakers, Zeliha Ozgur, et al.
Critical Reviews in Oncology/Hematology
|
July 15, 2010
The role of hypoxia inducible factor-1alpha in gynecological cancer
Laura M S Seeber, Nicole Horrée, Marc A G G Vooijs, et al.
Chemical Communications (Cambridge, England)
|
March 22, 2017
Protecting patches in colloidal synthesis of Au semishells
Daniel Mann, Stefanie Voogt, Ryan van Zandvoort, et al.
American Journal of Medical Genetics. Part A
|
March 27, 2020
Human RAD50 deficiency: Confirmation of a distinctive phenotype
Aviël Ragamin, Gökhan Yigit, Kristine Bousset, et al.
Molecular Genetics and Metabolism
|
October 16, 2010
Hemoglobin precipitation greatly improves 4-methylumbelliferone-based diagnostic assays for lysosomal storage diseases in dried blood spots
L F Oemardien, A M Boer, G J G Ruijter, et al.
Nano Letters
|
June 1, 2010
Paired twins and [112] morphology in GaP nanowires
Rienk E Algra, Marcel A Verheijen, Lou-Fé Feiner, et al.
Plos One
|
July 3, 2015
No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients
Jacob P Hoogendam, Ronald P Zweemer, Helena M Verkooijen, et al.
International Journal of Cancer
|
March 14, 2007
Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months
Saskia Bulk, Nicole W J Bulkmans, Johannes Berkhof, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 17, 1999
Differences between hereditary and sporadic ovarian cancer
R P Zweemer, R H Verheijen, F H Menko, et al.
Journal of Medicinal Chemistry
|
November 18, 2009
Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors
Arie Zask, Joshua Kaplan, Jeroen C Verheijen, et al.
Page
of 101
Search research articles
Search
Showing results (641-650 of 1,005) with videos related to
Sort By:
Page
of 101
Human Molecular Genetics
|
August 14, 2010
Transcriptional profiling of fibroblasts from patients with mutations in MCT8 and comparative analysis with the human brain transcriptome
W Edward Visser, Sigrid M A Swagemakers, Zeliha Ozgur, et al.
Critical Reviews in Oncology/Hematology
|
July 15, 2010
The role of hypoxia inducible factor-1alpha in gynecological cancer
Laura M S Seeber, Nicole Horrée, Marc A G G Vooijs, et al.
Chemical Communications (Cambridge, England)
|
March 22, 2017
Protecting patches in colloidal synthesis of Au semishells
Daniel Mann, Stefanie Voogt, Ryan van Zandvoort, et al.
American Journal of Medical Genetics. Part A
|
March 27, 2020
Human RAD50 deficiency: Confirmation of a distinctive phenotype
Aviël Ragamin, Gökhan Yigit, Kristine Bousset, et al.
Molecular Genetics and Metabolism
|
October 16, 2010
Hemoglobin precipitation greatly improves 4-methylumbelliferone-based diagnostic assays for lysosomal storage diseases in dried blood spots
L F Oemardien, A M Boer, G J G Ruijter, et al.
Nano Letters
|
June 1, 2010
Paired twins and [112] morphology in GaP nanowires
Rienk E Algra, Marcel A Verheijen, Lou-Fé Feiner, et al.
Plos One
|
July 3, 2015
No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients
Jacob P Hoogendam, Ronald P Zweemer, Helena M Verkooijen, et al.
International Journal of Cancer
|
March 14, 2007
Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months
Saskia Bulk, Nicole W J Bulkmans, Johannes Berkhof, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 17, 1999
Differences between hereditary and sporadic ovarian cancer
R P Zweemer, R H Verheijen, F H Menko, et al.
Journal of Medicinal Chemistry
|
November 18, 2009
Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors
Arie Zask, Joshua Kaplan, Jeroen C Verheijen, et al.
Page
of 101